To the full analysis
Buyback calculator for Tarsus Pharmaceuticals
Tarsus Pharmaceuticals stock: key metrics
TARSTarsus Pharmaceuticals had an operating margin of −15.7% and a return on invested capital (ROIC) of −15.5% in fiscal 2025.
Margins show how much of revenue is left over, returns on capital how hard the invested money works.
Daily figure as of 13 Nov 2026
Margins
- Gross margin
- Operating margin
- Net margin
Figures as a table
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| 2018 | no data | no data | no data |
| 2019 | no data | no data | no data |
| 2020 | no data | no data | no data |
| 2021 | 96.4% | −21.3% | −24.2% |
| 2022 | 96.3% | −242.9% | −240.5% |
| 2023 | 90.9% | −820.5% | −778.9% |
| 2024 | 93.0% | −65.9% | −63.2% |
| 2025 | 93.2% | −15.7% | −14.7% |
Returns on capital
- ROE
- ROIC
- ROA
Figures as a table
| Year | ROE | ROIC | ROA |
|---|---|---|---|
| 2018 | 97.4% | −48.3% | −55.2% |
| 2019 | 77.8% | −11.4% | −8.0% |
| 2020 | −16.2% | −19.0% | −15.6% |
| 2021 | −8.3% | −5.8% | −7.7% |
| 2022 | −32.2% | −26.1% | −27.2% |
| 2023 | −69.0% | −51.3% | −51.2% |
| 2024 | −51.5% | −36.3% | −30.7% |
| 2025 | −19.3% | −15.5% | −11.8% |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Weak, published since 7 Nov 2026 (in the score history since 31 Oct 2021)
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.